RecruitingRecruiting
Danish Pragmatic Randomized Trial to Evaluate the Effect of HeartLogic-Guided Management on Heart Failure Outcomes
NCT06099158 · Herlev and Gentofte Hospital
In plain English
Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.
About this study
The study is a pragmatic, registry-based, randomized controlled trial. Eligible patients in Denmark will be randomized 1:1 to either HeartLogic-guided management or usual care. During the trial, patients in the HeartLogic arm will be contacted by the study team in case of any HeartLogic alerts for evaluation and treatment decisions. There will be no mandatory in-person visits scheduled in the trial. HeartLogic alerts will be managed according to a prespecified management guide. Trial data besides device-related data will be retrieved from the Danish nationwide health registries including baseline information and endpoint data. The control group will receive usual HF care in the Danish health system without the involvement of the study team. The study will comply with the standards of the CONSORT statement and the principles of the Declaration of Helsinki.
Eligibility criteria
Inclusion Criteria:
1. Implanted with a CRT-D or ICD device that has HeartLogic capability and ability to change HeartLogic enablement per randomization
2. Age ≥18 years
3. Compliant with remote monitoring and not listed in the LATITUDE™ remote monitoring system as "not monitored"
Exclusion Criteria:
There are no specific exclusion criteria for the trial.
Study design
Enrollment target: 1428 participants
Allocation: randomized
Masking: single
Age groups: adult, older_adult
Timeline
Starts: 2024-05-31
Estimated completion: 2027-12-01
Last updated: 2026-10-29
Interventions
Other: HeartLogic
Primary outcomes
- • Composite endpoint of hospitalization for heart failure or all-cause death (first event) (42 months)
Sponsor
Tor Biering-Sørensen · other
With: Boston Scientific Corporation
Contacts & investigators
ContactFrederik Holme Fussing, MD · contact · frederik.holme.fussing@regionh.dk · +4521547157
ContactLise Witten Davodian, MD · contact · lise.witten.davodian@regionh.dk · +4521639531
InvestigatorTor Biering-Sørensen, MD, MSc, MPH, PhD · study_chair, Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte
All locations (5)
Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Cardiology, Copenhagen University Hospital - Herlev and GentofteRecruiting
Hellerup, Capital Region, Denmark
Aarhus University HospitalRecruiting
Aarhus, Denmark
RigshospitaletRecruiting
Copenhagen, Denmark
Odense University HospitalRecruiting
Odense, Denmark
Zealand University HospitalRecruiting
Roskilde, Denmark